Journal
CURRENT OPINION IN MICROBIOLOGY
Volume 13, Issue 5, Pages 551-557Publisher
CURRENT BIOLOGY LTD
DOI: 10.1016/j.mib.2010.09.008
Keywords
-
Categories
Funding
- National Institutes of Health
- Pew Charitable Trusts
- NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI090348] Funding Source: NIH RePORTER
Ask authors/readers for more resources
In the 80 years since their discovery the p-lactam antibiotics have progressed through structural generations, each in response to the progressive evolution of bacterial resistance mechanisms. The generational progression was driven by the ingenious, but largely empirical, manipulation of structure by medicinal chemists. Nonetheless, the true creative force in these efforts was Nature, and as the discovery of new beta-lectems from Nature has atrophied while at the same time multi-resistant and opportunistic bacterial pathogens have burgeoned, the time for empirical drug discovery has passed. We concisely summarize recent developments with respect to bacterial resistance, the identity of the new beta-lactams, and the emerging non-empirical strategies that will ensure that this incredible class of antibiotics has a future.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available